WEDERM Co., Ltd. is a Seoul-based medical aesthetics company founded in 2021, developing and exporting HA fillers, botulinum toxin, skin boosters, and lipolysis solutions under its own brand AETERDERM. WEDERM manages the full cycle from R&D to manufacturing and branding, and exports to around 30 countries across Asia, Russia/CIS, Europe, and the Americas.

At IMCAS World 2027, WEDERM presents AETERDERM PURILAX CE, a cross-linked hyaluronic acid dermal filler developed for precise correction, contouring, and volumization.

The PURILAX CE range contains 24 mg/mL of cross-linked HA and is available in three options: Fine, Deep, and Sub-Q. Each product offers a distinct rheological profile, from delicate correction to deeper contouring and volume restoration, PURILAX CE provides a versatile and complete filler solution for aesthetic professionals.

Visit the WEDERM booth to discover PURILAX CE and the complete AETERDERM PURI portfolio.